Kaynak: MarketBeat
Haber Ajansı
Hisse Senedi
Orta Önem
Health Catalyst Q2 Earnings Call Highlights
Health Catalyst NASDAQ: HCAT reported second-quarter 2026 revenue above the high end of its guidance range and adjusted EBITDA at the high end of its outlook, while outlining a strategic shift following the July 31 divestiture of its Vitalware and Med-Metrix businesses.
İlgili Semboller
1
H
HCAT
HCAT
Kaynak: MarketBeat
Kaynağı Ziyaret Et